Allergic Asthma
Respiratory
6
Pipeline Programs
4
Companies
5
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
5
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Monoclonal Antibody
3100%
+ 3 programs with unclassified modality
Competitive Landscape
4 companies ranked by most advanced pipeline stage
GenentechCA - Oceanside
3 programs3
ANTI-IGE THERAPYPhase 4
OmalizumabPhase 4Monoclonal Antibody1 trial
OmalizumabPhase 4Monoclonal Antibody1 trial
Active Trials
Jasper TherapeuticsREDWOOD CITY, CA
1 program1
BriquilimabPhase 1Monoclonal Antibody1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
GenentechOmalizumab
HELP TherapeuticsInhaled corticosteroid
NovartisANTI-IGE THERAPY
GenentechOmalizumab
Jasper TherapeuticsBriquilimab
Clinical Trials (5)
Total enrollment: 221 patients across 5 trials
A Study Evaluating the Persistency of Response With or Without Xolair (Omalizumab) After Long-term Therapy
Start: May 2010Est. completion: Aug 2013176 patients
Phase 4Completed
Utility of Versican and Hyaluronan Measurement in Induced Sputum as Biomarkers of Asthma
Start: Aug 2009Est. completion: Nov 201010 patients
Phase 4Completed
A Description of Inflammatory Cell Types In Moderate to Severe Pediatric Asthma: Eosinophilic and Non Eosinophilic Sputum Markers While on Anti-IgE Therapy
Start: Jan 2006Est. completion: Jan 200913 patients
Phase 4Completed
Effect of Xolair on Airway Hyperresponsiveness
Start: Jan 2004Est. completion: Sep 201122 patients
Phase 4Unknown
A Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Briquilimab in Participants With Allergic Asthma
Start: Nov 2024Est. completion: Aug 2025
Phase 1Terminated
Related Jobs in Respiratory
Regional Gene Therapy Consultant - Upper Midwest (IL/WI/MN)
Krystal Biotech
6m ago
$185K - $215K/yr
Regional Gene Therapy Consultant - Southwest (CO/AZ/NM/UT)
Krystal Biotech
6m ago
$185K - $215K/yr
Marketing Intern – Vertex Iberia (Spain)
Vertex Pharmaceuticals
Madrid, Spain
Yesterday
Sales Rep Neurology Region Leipzig, Halle, Gera, Jena, Weimar DE_G2M110105 - befristet bis 31.03.2027 (all genders)
Sanofi
Berlin
Yesterday
Ausbildung zum Pharmakanten (m/w/d)
Ferring Pharmaceuticals
Kiel, Germany
Yesterday
Laboratory Assistant (m/w/d)
Ferring Pharmaceuticals
Kiel, Germany
2d ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
Monoclonal Antibody is the dominant modality (100% of programs)
4 companies competing in this space